Literature DB >> 1319246

Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.

K Kawai1, A Kawai.   

Abstract

Among 1,153 consecutive patients, 22 patients (1.9%) who complained of chronic fatigue for a period of over 6 months without detectable causes were studied. Ten patients (0.86%) satisfied the criteria of chronic fatigue syndrome (CFS) and were classified to be definite cases of CFS. The other patients were classified as probable cases. In order to clarify the role of Epstein-Barr virus (EBV) as a cause of CFS, we measured various antibodies for EBV. The definite cases had significantly higher titers of early antigen complex (EA)-IgG than both the probable cases and controls. We proposed the EA-IgG/EBNA ratio as the indicator of activation of EBV and attempted to estimate the degree of fatigue by the EA-IgG/EBNA ratio. The highest ratio value (16.0) of the 22 patients ratios was the most serious case. In general, the ratio correlated with the degree of fatigue. Based on these results, it was concluded that a relationship does exist between CFS and EBV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319246     DOI: 10.2169/internalmedicine.31.313

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Characteristics of chronic fatigue syndrome in a Japanese community population : chronic fatigue syndrome in Japan.

Authors:  Masahide Hamaguchi; Yutaka Kawahito; Noriyuki Takeda; Takahiro Kato; Takao Kojima
Journal:  Clin Rheumatol       Date:  2011-02-08       Impact factor: 2.980

2.  Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.

Authors:  Amal Elfaitouri; Björn Herrmann; Agnes Bölin-Wiener; Yilin Wang; Carl-Gerhard Gottfries; Olof Zachrisson; Rϋdiger Pipkorn; Lars Rönnblom; Jonas Blomberg
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

3.  Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.

Authors:  Madlen Loebel; Kristin Strohschein; Carolin Giannini; Uwe Koelsch; Sandra Bauer; Cornelia Doebis; Sybill Thomas; Nadine Unterwalder; Volker von Baehr; Petra Reinke; Michael Knops; Leif G Hanitsch; Christian Meisel; Hans-Dieter Volk; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

4.  Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Authors:  Madlen Loebel; Maren Eckey; Franziska Sotzny; Elisabeth Hahn; Sandra Bauer; Patricia Grabowski; Johannes Zerweck; Pavlo Holenya; Leif G Hanitsch; Kirsten Wittke; Peter Borchmann; Jens-Ulrich Rüffer; Falk Hiepe; Klemens Ruprecht; Uta Behrends; Carola Meindl; Hans-Dieter Volk; Ulf Reimer; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

5.  Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Jonas Blomberg; Muhammad Rizwan; Agnes Böhlin-Wiener; Amal Elfaitouri; Per Julin; Olof Zachrisson; Anders Rosén; Carl-Gerhard Gottfries
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

Review 6.  Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

Authors:  Manuel Ruiz-Pablos; Bruno Paiva; Rosario Montero-Mateo; Nicolas Garcia; Aintzane Zabaleta
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 7.  A clinical primer for the expected and potential post-COVID-19 syndromes.

Authors:  Brian Walitt; Elizabeth Bartrum
Journal:  Pain Rep       Date:  2021-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.